Compare Stryker Corporation (SYK) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Stryker Corporation trades at $277.45 (market cap $105.63B), while YieldMax TSLA Option Income Strategy ETF trades at $22.51. The key difference: Stryker Corporation pays a 1.28% dividend while YieldMax TSLA Option Income Strategy ETF pays none. Which is the better fit depends on your goals.
| SYK | TSLY | |
|---|---|---|
Market Cap | $105.63B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $388.79 | $48.25 |
52-Week Low | $275.39 | $20.49 |
Enterprise Value | $117.10B | — |
Dividend Yield | 1.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.
Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.
TSLY trades at $22.79, up 3.17% over 24 hours, with a bullish technical signal supported by positive ADX readings. The ETF maintains a consistent weekly dividend payout strategy, with recent distributions ranging from $0.18 to $0.28 per share. However, key valuation and profitability ratios are unavailable, limiting fundamental clarity.
The outlook balances high income potential against capital erosion risks, as noted in recent analysis. Upside is constrained by Tesla's volatility dynamics, while dividend sustainability depends on option income generation. Investor caution is warranted given the lack of traditional financial metrics and mixed sentiment from financial media.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
